Sitafloxacin shows promising in vitro activity against Mycobacterium ulcerans infection

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1368, 2002-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fosmidomycin shows promising antimalarial activity

Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

MDX 018 shows promising activity in the treatment of an undisclosed autoimmune disease

Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Citalopram shows promising activity in recurrent abdominal pain in children and adolescents

Inpharma, Vol. 1, Iss. 1466, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Susceptibility of Mycobacterium ulcerans to a combination of amikacin/rifampicin

By Marsollier L. Prevot G. Honore N. Legras P. Manceau A.-L. Payan C. Kouakou H. Carbonnelle B.

International Journal of Antimicrobial Agents, Vol. 22, Iss. 6, 2003-12 ,pp. : 562-566

Elsevier

Access to resources Recommend Favorite

Role of Type I Cytokines in Host Defense Against Mycobacterium avium Infection

Current Pharmaceutical Design, Vol. 9, Iss. 1, 2003-01 ,pp. : 61-65

Bentham Science Publishers

Access to resources Recommend Favorite